
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES184
An RCT288 comparing treatment with rosuvastatin 10 mg vs atorvastatin 10 mg, reported that both treatments were well tolerated, with overall incidences of AEs being similar between the groups. According to the study ten patients discontinued because of AEs, three in the rosuvastatin group and seven in the atorvastatin group. There were no cases of myopathy. Level 1+

[@Berne_2005]

